We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » AAM Pushes Back Against Senate Drug Pricing Bill
Generic drug makers are pushing back against a new Senate bill over concerns that proposals to revise patent arbitrage will deter generics from reaching the market.